Skip to content
Subscriber Only

Health-Care Banker Chris Hite Leaves Citi for Royalty Pharma

  • Hite was head of Citigroup’s global health-care group
  • Royalty Pharma invests in revenue streams from drugs
Updated on

Chris Hite, a top Citigroup Inc. health-care dealmaker, is leaving the firm.

Hite, head of the New York-based bank’s global health-care group for 12 years, will join Royalty Pharma, according to people familiar with the matter, who asked to not be identified because the matter is private. Royalty Pharma is a private company that invests in revenue streams from drugs.